Eligible projects must focus on fundamental, pre-clinical, or translational research exploring biochemical action mechanisms in cancer, such as protein-protein/protein-DNA interactions, tumor heterogeneity, and metastasis. Proposals using novel ex vivo models or high-resolution single-cell omics are particularly encouraged.
Budget: 225.000 euro
Deadline: 18 May 2026